Results 151 to 160 of about 19,810 (202)

Effectiveness and tolerability of bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) in people with HIV (PWH) in routine clinical practice in Türkiye: 12-month outcomes from the KLIMIK HIV-TR cohort. [PDF]

AIDS Res Ther
Akalın H, İnan A, Kaya B, Gökengin D, İnan D, Görenek L, Özdemir HÖ, Altunsoy A, Aydin M, Şimşek F, Çağatay A, Kutlu SS, Asan A, Atalay S, Birengel S, Korten V, KLİMİK HIV TR Working Group - Turkish Society of Clinical Microbiology and Infectious Diseases(KLİMİK).   +16 more
europepmc   +1 more source

Renal Outcomes in People With HIV-1 and Renal Impairment Treated With Bictegravir/Emtricitabine/Tenofovir Alafenamide: Integrated Analysis From 9 Phase 3/3b Clinical Trials. [PDF]

Open Forum Infect Dis
Post FA, Wohl D, Liegeon G, Brar I, Hagins D, Yazdanpanah Y, Avihingsanon A, Liu H, Aizen K, Hindman JT, Gupta S.   +10 more
europepmc   +1 more source

Eight-year Results from Two Randomized Phase 3 Trials of Tenofovir Alafenamide for Chronic Hepatitis B Virus Infection in China. [PDF]

J Clin Transl Hepatol
Hou J, Ning Q, Duan Z, Chen Y, Xie Q, Zhang L, Wu S, Tang H, Li J, Lin F, Yang Y, Gong G, Luo Y, Chen Y, Abramov F, Yee LJ, Wang H, Mateo R, Yazdi T, Botros I, Chen C, Huang Y, Zhang M, Jia J.   +23 more
europepmc   +1 more source

Efficacy and Safety of Tenofovir Alafenamide Fumarate and Tenofovir Disoproxil Fumarate for Preventing Mother-to-Child Transmission of Hepatitis B in Treatment-Naïve mothers: An Observational Study. [PDF]

Virol J
Yang X, Chen J, Duan L, Li X, Cheng W, Chen Y, Huang Y, Huang Z.   +7 more
europepmc   +1 more source

Evaluation of the Efficacy of Tenofovir Alafenamide in Patients with Low-Level Viremia Under Chronic Hepatitis B Treatment. [PDF]

Viruses
Tahmaz A, Yıldız Dikmen M, Yıldırım F, Öztürk Kaygusuz T, Karabay O, Çelen MK, Alkan S, Damar Çakırca T, Akgül F, Akhan S, Gürbüz E, Özer Balin Ş, Çelik M, Çabalak M.   +13 more
europepmc   +1 more source

Effectiveness and safety of bictegravir/emtricitabine/tenofovir alafenamide in people with HIV in Asia: 24-Month findings from the observational BICSTaR study. [PDF]

Medicine (Baltimore)
Yang CJ, Kim YS, Choi JY, Choy CY, Lu PL, Tsai HC, Ryu J, Harrison R, Chang J, Mo B, Lee SH, Hung CC.   +11 more
europepmc   +1 more source

Effectiveness and Safety of Bictegravir/Emtricitabine/Tenofovir Alafenamide in People with HIV: A Real-World Data from the Spanish BICSTaR Cohort. [PDF]

HIV AIDS (Auckl)
Inciarte A, Miralles C, Silva-Klug A, Revollo B, García Deltoro M, Portilla J, Antela A, Castaño Carracedo MÁ, De Álvaro C, Ramroth J, González-Cordón A, Mallolas J.   +11 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Tenofovir Alafenamide

Annals of Pharmacotherapy, 2016
Objective: To review the pharmacology, efficacy, safety, and place in therapy for tenofovir alafenamide (TAF). Data Sources: A search using PubMed was conducted (2004 to May 2016) using the following keywords: tenofovir alafenamide, TAF, and GS-7340. Articles were evaluated for content, and bibliographies were reviewed.

exaly   +3 more sources